Income Statement Align Technology, Inc.
Equities
ALGN
US0162551016
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
243.73 USD | +6.50% | +10.21% | -11.05% |
10/09 | Transcript : Align Technology, Inc. Presents at Baird's 2024 Global Healthcare Conference, Sep-10-2024 09:05 AM | |
04/09 | Align Technology Announces New Regional Leadership Roles | CI |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2.41B | 2.47B | 3.95B | 3.73B | 3.86B | |||||
Total Revenues | 2.41B | 2.47B | 3.95B | 3.73B | 3.86B | |||||
Cost of Goods Sold, Total | 663M | 709M | 1.02B | 1.1B | 1.14B | |||||
Gross Profit | 1.74B | 1.76B | 2.94B | 2.64B | 2.72B | |||||
Selling General & Admin Expenses, Total | 1.07B | 1.2B | 1.71B | 1.67B | 1.7B | |||||
R&D Expenses | 157M | 175M | 250M | 305M | 347M | |||||
Other Operating Expenses | - | - | - | 53K | 13.32M | |||||
Other Operating Expenses, Total | 1.23B | 1.38B | 1.96B | 1.98B | 2.06B | |||||
Operating Income | 514M | 387M | 976M | 657M | 657M | |||||
Interest And Investment Income | 12.48M | 3.12M | 3.1M | 5.37M | 17.26M | |||||
Net Interest Expenses | 12.48M | 3.12M | 3.1M | 5.37M | 17.26M | |||||
Income (Loss) On Equity Invest. | -7.53M | - | - | - | - | |||||
Currency Exchange Gains (Loss) | -2M | 6.8M | -13.3M | -43.8M | -7M | |||||
Other Non Operating Income (Expenses) | -2.09M | -2.06M | 2.82M | -5.1M | -12.39M | |||||
EBT, Excl. Unusual Items | 515M | 395M | 969M | 613M | 655M | |||||
Restructuring Charges | - | - | - | -10.2M | -13.3M | |||||
Merger & Related Restructuring Charges | - | -10.2M | - | - | - | |||||
Gain (Loss) On Sale Of Investments | 11.77M | -5.89M | - | - | - | |||||
Asset Writedown | - | - | - | -1.8M | - | |||||
Legal Settlements | 28.01M | - | 43.4M | - | - | |||||
Other Unusual Items | - | - | - | -2.3M | - | |||||
EBT, Incl. Unusual Items | 555M | 379M | 1.01B | 599M | 641M | |||||
Income Tax Expense | 112M | -1.4B | 240M | 237M | 196M | |||||
Earnings From Continuing Operations | 443M | 1.78B | 772M | 362M | 445M | |||||
Net Income to Company | 443M | 1.78B | 772M | 362M | 445M | |||||
Net Income - (IS) | 443M | 1.78B | 772M | 362M | 445M | |||||
Net Income to Common Incl Extra Items | 443M | 1.78B | 772M | 362M | 445M | |||||
Net Income to Common Excl. Extra Items | 443M | 1.78B | 772M | 362M | 445M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 5.57 | 22.55 | 9.78 | 4.62 | 5.82 | |||||
Basic EPS - Continuing Operations | 5.57 | 22.55 | 9.78 | 4.62 | 5.82 | |||||
Basic Weighted Average Shares Outstanding | 79.42M | 78.76M | 78.92M | 78.19M | 76.43M | |||||
Net EPS - Diluted | 5.53 | 22.41 | 9.69 | 4.61 | 5.81 | |||||
Diluted EPS - Continuing Operations | 5.53 | 22.41 | 9.69 | 4.61 | 5.81 | |||||
Diluted Weighted Average Shares Outstanding | 80.1M | 79.23M | 79.67M | 78.42M | 76.57M | |||||
Normalized Basic EPS | 4.06 | 3.13 | 7.67 | 4.9 | 5.35 | |||||
Normalized Diluted EPS | 4.02 | 3.12 | 7.6 | 4.89 | 5.34 | |||||
American Depositary Receipts Ratio (ADR) | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | |||||
Supplemental Items | ||||||||||
EBITDA | 599M | 481M | 1.09B | 783M | 799M | |||||
EBITA | 520M | 401M | 993M | 673M | 673M | |||||
EBIT | 514M | 387M | 976M | 657M | 657M | |||||
EBITDAR | 624M | 510M | 1.13B | 843M | 860M | |||||
Effective Tax Rate - (Ratio) | 20.24 | -368.64 | 23.75 | 39.64 | 30.59 | |||||
Current Domestic Taxes | 85.7M | 64.15M | 186M | 223M | 163M | |||||
Current Foreign Taxes | 28.36M | 29.4M | 42.68M | 56.54M | 51.31M | |||||
Total Current Taxes | 114M | 93.55M | 228M | 279M | 214M | |||||
Deferred Domestic Taxes | 1.44M | -13.87M | -31.46M | -67.84M | -19.96M | |||||
Deferred Foreign Taxes | -3.16M | -1.48B | 43.43M | 26.12M | 1.94M | |||||
Total Deferred Taxes | -1.71M | -1.49B | 11.97M | -41.72M | -18.02M | |||||
Normalized Net Income | 322M | 247M | 606M | 383M | 409M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 119M | 161M | 326M | - | - | |||||
Selling and Marketing Expenses | 119M | 161M | 326M | - | - | |||||
General and Administrative Expenses | - | - | - | - | - | |||||
Research And Development Expense From Footnotes | 157M | 175M | 250M | 305M | 347M | |||||
Net Rental Expense, Total | 24.68M | 29.25M | 44.38M | 60M | 60.63M | |||||
Stock-Based Comp., COGS (Total) | 5.15M | 4.72M | 5.63M | 6.44M | 7.46M | |||||
Stock-Based Comp., R&D Exp. (Total) | 13.21M | 15.21M | 18.04M | 23.8M | 30.57M | |||||
Stock-Based Comp., S&M Exp. (Total) | - | - | - | - | - | |||||
Stock-Based Comp., G&A Exp. (Total) | - | - | - | - | - | |||||
Stock-Based Comp., SG&A Exp. (Total) | 69.82M | 78.5M | 90.66M | 103M | 116M | |||||
Total Stock-Based Compensation | 88.18M | 98.43M | 114M | 133M | 154M |